Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abeona, Albireo, Arrowhead, Astrazeneca, Aurinia, Beigene, EMD Serono, Eusa, Iterum, Junshi, Pfizer, Waymade.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: AB, Acer, Achilles, Atyr, Biovaxys, Elasmogen, Emergent, Evozyne, GB, Humanigen, Novavax, Nyrada, Ose, Pharmadrug, Piramal, Quercis, Relief, Sairiyo, Samsung Bioepis, Saniona, Seneca, Sonnet, Takeda, Therapeutic Solutions, Theratechnologies, Valneva.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alector, Antios, Astrazeneca, Durect, Dynavax, Exelixis, Genentech, Macrogenics, Medigen, Synairgen, Zydus.

Biopharmas raising money in public or private financings, including: Biolinerx, Bridgebio, Cellvie, Citius, Evaxion, Fulcrum, Wren .

New hires and promotions in the biopharma industry, including: Atea, Awakn, Cidara, Cyclerion, Diversigen, Novavax, Noveome, Tmunity, Vericel.

The latest global regulatory news, changes and updates affecting biopharma, including: And now the state cases; Advamed urges administration to communicate on DPA; Looking for GCP volunteers.

Total raised in public, private and other financings of biopharma companies, comparing 2021 vs. 2020 vs. 2019.

Year-to-date money raised in public, private and other financings of biopharma companies.

The top 10 biopharma stock gainers and losers for the week.